BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 27926989)

  • 1. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.
    Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML
    PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
    Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
    J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis.
    Rubinstein E; Cho JY; Rosenthal P; Chao J; Miller M; Pham A; Aceves SS; Varki A; Broide DH
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):409-16. PubMed ID: 21970996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mouse Model for Eosinophilic Esophagitis (EoE).
    Dsilva A; Avlas S; Rhone N; Itan M; Munitz A
    Curr Protoc; 2024 Feb; 4(2):e993. PubMed ID: 38372429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.
    Ben Baruch-Morgenstern N; Mingler MK; Stucke E; Besse JA; Wen T; Reichman H; Munitz A; Rothenberg ME
    J Immunol; 2016 Aug; 197(3):707-14. PubMed ID: 27324131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal Expression of Active IκB Kinase-β in Mice Up-Regulates Tumor Necrosis Factor and Granulocyte-Macrophage Colony-Stimulating Factor, Promoting Inflammation and Angiogenesis.
    Tétreault MP; Weinblatt D; Ciolino JD; Klein-Szanto AJ; Sackey BK; Twyman-Saint Victor C; Karakasheva T; Teal V; Katz JP
    Gastroenterology; 2016 Jun; 150(7):1609-1619.e11. PubMed ID: 26896735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis.
    Vimalathas P; Farris A; Letner D; Deshpande V; Yajnik V; Shreffler W; Garber J
    Immunol Cell Biol; 2018 Apr; 96(4):426-438. PubMed ID: 29424023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families.
    Straumann A; Blanchard C; Radonjic-Hoesli S; Bussmann Ch; Hruz P; Safroneeva E; Simon D; Schoepfer AM; Simon HU
    Allergy; 2016 Jun; 71(6):889-900. PubMed ID: 26970242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
    Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
    Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study.
    Durchschein F; Eherer A; Grill M; Sturm EM; Pommer V; Langner C; Högenauer C; Schicho R
    Dig Dis Sci; 2019 Oct; 64(10):2806-2814. PubMed ID: 30989466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
    Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation.
    Simon D; Radonjic-Hösli S; Straumann A; Yousefi S; Simon HU
    Allergy; 2015 Apr; 70(4):443-52. PubMed ID: 25620273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad3-deficient mice have reduced esophageal fibrosis and angiogenesis in a model of egg-induced eosinophilic esophagitis.
    Cho JY; Doshi A; Rosenthal P; Beppu A; Miller M; Aceves S; Broide D
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):10-6. PubMed ID: 24590208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
    Doyle AD; Masuda MY; Kita H; Wright BL
    Front Immunol; 2020; 11():603295. PubMed ID: 33335531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
    Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
    J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Hamilos DL; Leung DY; Wood R; Meyers A; Stephens JK; Barkans J; Meng Q; Cunningham L; Bean DK; Kay AB
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):39-48. PubMed ID: 8335853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
    Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
    Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
    Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
    Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.